SHL Group is exhibiting at the 2019 BIO International Convention in Philadelphia, Pennsylvania, USA from June 3-6.
SHL will showcase its vast portfolio of drug delivery systems designed to accommodate a wide range of drugs and biologics in a variety of volumes and viscosities. SHL representatives will also introduce its vertically integrated solutions for device development programs, including precision design and engineering capabilities, turnkey solutions for final assembly, labeling, and packaging, as well analytical testing solutions for both sub-assemblies and fully assembled combination products.
This will mark SHL's third year participating in the annual event. Business Development Director, Taras Seniuch, commented: "SHL understands the intricacies of the self-injection process and the complexities of combination product development timelines. SHL combines years of knowledge and experience with a strong set of in-house capabilities to help our partners ensure the successful commercialization of their combination product in a timely manner. We're excited to meet with our partners from across the biotech industry to learn how we can further support their drug development programs."
Bio International attracts more than 16,000 industry leaders from over 7,000 companies worldwide and it is the largest global networking and exhibiting event for the biotechnology industry.
To learn more, visit SHL at Booth 2455 at the Pennsylvania Convention Center.
瑞健目前全球已有超過 4,000 名員工，主要分為以下事業群：
SHL Medical 主要為製藥和生技企業設計、研發、及製造高科技藥物傳輸系統，也提供終端組裝、醫材標籤及包裝相關服務
SHL Healthcare 從事居家及醫院護理器材之研發製造
SHL Technologies 提供醫療科技及工業設備之 OEM 製造與相關服務